Department of Respiratory and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Department of Respiratory and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Microb Pathog. 2021 Jul;156:104903. doi: 10.1016/j.micpath.2021.104903. Epub 2021 May 1.
To investigate the distribution and risk factors of pathogens in secondary pulmonary infection in patients with COVID-19.142 patients with confirmed COVID-19 from Shanghai Public Health Clinical Center were collected, and 32 patients with pulmonary infection were taken as the infection group. The distribution of pathogens in the sputum specimens was applied for retrospective analysis. Meanwhile, 110 patients diagnosed with COVID-19, but without pulmonary infection were regarded as the asymptomatic group. The risk factors of pulmonary infection were analyzed with generalized linear models and logistic regression. The pathogens in the lung infection group were mainly gram-negative bacteria (22, 68.8%), especially Klebsiella pneumoniae. Gram-positive bacteria and fungi accounted for 13 (40.6%), mainly Staphylococcus aureus, and 11 (34.4%), mainly Candida albicans. There were 14 cases (43.8%) infected with two or more pathogens. The comparison between the two groups found that, patients with elder age, underlying diseases, more lung lesions and low protein contents, were more likely to develop lung infections. At last, univariate analysis showed that 6 factors, including indwelling gastric catheter, the number of deep vein catheters, tracheal intubation tracheotomy, invasive mechanical ventilation, hormonal application, and the use of more than three antibacterial drugs, are risk factors for COVID-19 secondary pulmonary infection. Generalized linear models and logistic regression analysis showed antimicrobial use as an independent risk factor for COVID-19 secondary lung infection. There are many risk factors for secondary lung infection in severe COVID-19 patients, and it is recommended to use antibiotics reasonably.
为了调查 COVID-19 患者继发性肺部感染病原体的分布和危险因素。我们收集了来自上海公共卫生临床中心的 142 例确诊 COVID-19 患者,其中 32 例肺部感染患者作为感染组。应用回顾性分析痰液标本中病原体的分布。同时,选择 110 例诊断为 COVID-19,但无肺部感染的患者作为无症状组。采用广义线性模型和 logistic 回归分析肺部感染的危险因素。感染组肺部感染的病原体主要为革兰氏阴性菌(22,68.8%),特别是肺炎克雷伯菌。革兰氏阳性菌和真菌占 13 例(40.6%),主要为金黄色葡萄球菌,11 例(34.4%),主要为白色念珠菌。有 14 例(43.8%)感染两种或两种以上病原体。两组比较发现,年龄较大、有基础疾病、肺部病变较多、蛋白含量较低的患者更容易发生肺部感染。最后,单因素分析显示,留置胃管、深静脉置管数、气管插管气管切开、有创机械通气、激素应用、使用三种以上抗菌药物等 6 个因素是 COVID-19 继发性肺部感染的危险因素。广义线性模型和 logistic 回归分析显示抗菌药物的使用是 COVID-19 继发性肺部感染的独立危险因素。重症 COVID-19 患者继发性肺部感染的危险因素较多,建议合理使用抗生素。